Advertisement
research summary
research summary
09/21/2023

Leigh Precopio

Leigh Precopio
In a recent study, researchers examined the prevalence of comorbidities and risk factors in individuals with newly diagnosed psoriatic arthritis.
09/21/2023
Research Summary
Research Summary
08/16/2023

Anthony Calabro, MA

Anthony Calabro, MA
In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.
08/16/2023
Research Summary
Research Summary
08/10/2023

Anthony Calabro, MA

Anthony Calabro, MA
In a post hoc analysis of the EXCEED study, researchers found that secukinumab and adalimumab—two biologic disease-modifying antirheumatic medications—showed similar efficacy in the resolution of enthesitis...
08/10/2023
research summary
research summary
06/21/2023

Leigh Precopio

Leigh Precopio
Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.
06/21/2023
research summary
research summary
05/16/2023

Leigh Precopio

Leigh Precopio
To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...
05/16/2023
Research Summary
Research Summary
04/28/2023

Jessica Ganga

Jessica Ganga
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
04/28/2023
Research Summary
Research Summary
04/13/2023

Jessica Ganga

Jessica Ganga
Researchers conducted a trial to investigate the use of cannabidiol (CBD) to help manage pain in patients with psoriatic arthritis and hand osteoarthritis.
04/13/2023
research summary
research summary
03/21/2023
The authors of a recent study aimed to determine if the use of routine ultrasound could be an effective tool for screening patients with psoriasis for subclinical psoriatic arthritis.
03/21/2023
treatment
treatment
11/28/2022
Researchers compared if early initiation of disease modifying antirheumatic drugs for the treatment of psoriatic arthritis was superior to later initiation of therapy after diagnosis in a recent study...
11/28/2022
treatment
treatment
11/21/2022
In a recent study presented at ACR Convergence 2022, researchers compared the rates of improvement and associated outcomes of upadacitinib with adalimumab for the treatment of individuals with psoriatic...
11/21/2022